Journal
GENE THERAPY
Volume 16, Issue 10, Pages 1180-1188Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/gt.2009.102
Keywords
HACs; BACs; YACs; amplicons; genomic transgenes; stem cells
Ask authors/readers for more resources
Artificial chromosomes (ACs) are highly promising vectors for use in gene therapy applications. They are able to maintain expression of genomic-sized exogenous transgenes within target cells, without integrating into the host genome. Although these vectors have huge potential and benefits when compared against normal expression constructs, they are highly complex, technically challenging to construct and diffcult to deliver to target cells. This review focuses on the current progress in the field of ACs and discusses the recent advances in purification, construction, delivery and potential new molecular therapies. Gene Therapy (2009) 16, 1180-1188; doi: 10.1038/gt.2009.102; published online 27 August 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available